Evidence-based testing for detection and identification
Our internationally renowned clinical microbiology laboratories offer a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases. We have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization, as well as provision of treatment guidance for microbial pathogens.
“We're always trying to develop new methods, broader methods, faster methods, less expensive methods.”
Nancy Wengenack, Ph.D., Division of Clinical Microbiology
Our difference
News and updates
The latest
William Morice II, M.D., Ph.D., recently joined the Advisory Board for a webinar discussion on 2024 lab market trends. Dr. Morice covered the current lab market outlook, the priority trends, and opportunities for future growth.
A recent article in HealthDay News reported on a case of an avid 26-year-old outdoorswoman from Oregon who became the first human ever infected by a type of eye worm previously seen only in cattle. Audrey Schuetz, M.D., Senior Associate Consultant in the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic, comments on the eye worm.
A recent BuzzFeed article reported on 22-year-old Katie Stephens and her boyfriend, Eddie Zytner, a Canadian couple who recently went on a beach vacation in the Dominican Republic. During their vacation, they both developed cutaneous larva migrans, a skin infection caused by hookworms. Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and Pathology, weighs in on the infection.
In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.
The Rochester Post-Bulletin recently highlighted Bobbi Pritt, M.D.'s, “Creepy, Dreadful, Wonderful Parasites” blog, which celebrated its 10-year anniversary in October with a parasite-themed art contest and giveaways.
Mayo Clinic and the University of Notre Dame’s Eck Institute for Global Health have launched a four-tiered joint project to better characterize and further assist in the detection of vector-borne infectious diseases in Belize.
In the war against microbes, human beings are vastly outnumbered—and losing the weapons race.
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Mayo’s Vector-Borne Diseases Laboratory Services, co-authored an article review in the Journal of Clinical Microbiology on an update on malaria diagnostics and test utilization.
The algorithm can be viewed here.
An algorithm is a step-by-step procedure to guide clinicians and laboratorians in appropriate laboratory test ordering.
In the United States, Lyme disease is caused by "Borrelia burgdorferi" and "Borrelia mayonii" bacteria, carried primarily by "black-legged" or "deer ticks." To learn more about Lyme disease, the Mayo Clinic Department of Laboratory Medicine and Pathology and its reference laboratory Mayo Medical Laboratories have developed “The ABCs of Lyme Disease” flash cards.
To help you learn more about Lyme disease, “The ABCs of Lyme Disease” flash cards include information about symptoms, treatment, and other important facts.
Once confined to the southern part of the U.S., the lone star tick is now being found further north and west, and so are reports of allergic reactions to meat following a tick bite. Bobbi Pritt, M.D., Medical Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Laboratory Services at Mayo Clinic, weighs in.